A sensitive two-site sandwich enzyme immunoassay for human angiotensin converting enzyme utilizing monoclonal antibodies.
A sensitive enzyme immunoassay was developed for human angiotensin converting enzyme. Monoclonal antibodies specific for two unique converting enzyme epitopes were utilized to develop a two-site sandwich enzyme immunoassay. Alkaline phosphatase conjugated to the detecting antibody hydrolyzes nicotinamide adenine dinucleotide phosphate (NADP) to NAD. Subsequently, NAD is cycled between its reduced and oxidized forms by an alcohol dehydrogenase/diaphorase catalyzed redox cycle. Each cycle converts iodonitrotetrazolium violet to a highly colored formazan which is quantitated. With this assay, as little as 94 pg/ml of native converting enzyme is detectable without interference from either therapeutic or endogenous converting enzyme inhibitors.
New England Medical Center, Pulmonary Division, Boston, MA 02111.
J
J
Stevens
S
S
Danilov
B L
BL
Fanburg
J J
JJ
Lanzillo
D000818:Animals; D000911:Antibodies, Monoclonal; D002216:Captopril / Q000494:pharmacology; D002417:Cattle; D003429:Cross Reactions; D004306:Dose-Response Relationship, Immunologic; D004656:Enalapril / Q000031:analogs & derivatives / Q000494:pharmacology; D000939:Epitopes; D006801:Humans; D007124:Immunoenzyme Techniques; D017706:Lisinopril; D007703:Peptidyl-Dipeptidase A / Q000032:analysis*; D011489:Protein Denaturation
D000911:Antibodies, Monoclonal; D000939:Epitopes; D004656:Enalapril; D002216:Captopril; D017706:Lisinopril; D007703:Peptidyl-Dipeptidase A